Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Multicenter Observational Study in NSCLC Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutation Treated First Line by Tyrosine Kinase Inhibitor (TKI)

NCT02293733 is registered in ClinicalTrials.gov with Groupe Francais De Pneumo-Cancerologie as lead sponsor.

NCT NCT02293733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02293733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Multicenter Observational Study in NSCLC Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutation Treated First Line by Tyrosine Kinase Inhibitor (TKI)
Lead sponsor
Groupe Francais De Pneumo-Cancerologie
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
March 31, 2014
Enrollment
144 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc non small cells lung cancer